Currency in SEK
Last close As at 06/02/2023
▲ −0.18 (−3.30%)
Edison Investment Research is terminating coverage on AlzeCure Pharma. Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.
Previously published reports can still be accessed via our website.
|52 week high/low||SEK7.6/SEK2.2|
AlzeCure Pharma is a clinical-stage biotech company based in Sweden focused on developing innovative, small molecule drugs for the treatment of Alzheimer’s disease (symptomatic as well as disease modifying) and pain (neuropathic and osteoarthritic).
|Y/E Dec||Revenue (SEKm)||EBITDA (SEKm)||PBT (SEKm)||EPS (öre)||P/E (x)||P/CF (x)|